Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 92,799,600
- Total 13F shares
- 17,450,658
- Share change
- -577,730
- Total reported value
- $110,112,206
- Price per share
- $6.31
- Number of holders
- 56
- Value change
- -$24,376,594
- Number of buys
- 33
- Number of sells
- 19
Report period
Q4 2018
Institutions
56
Top holders
10
XENE full security history
Newer quarter: Q1 2019
Previous quarter: Q3 2018
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Top shareholders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
|
Company |
2.6%
|
2,367,218
|
$31,247,000 | — | 30 Sep 2018 | |
| Vivo Capital, LLC |
13F
|
Company |
1.5%
|
1,405,476
|
$18,552,000 | — | 30 Sep 2018 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
1,200,000
|
$15,840,000 | — | 30 Sep 2018 | |
| BVF INC/IL |
13F
|
Company |
1.3%
|
1,165,553
|
$15,385,000 | — | 30 Sep 2018 | |
| Capital World Investors |
13F
|
Company |
1%
|
963,500
|
$12,718,000 | — | 30 Sep 2018 | |
| Capital International Investors |
13F
|
Company |
1%
|
937,400
|
$12,374,000 | — | 30 Sep 2018 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.97%
|
895,553
|
$11,821,000 | — | 30 Sep 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.81%
|
753,935
|
$9,952,000 | — | 30 Sep 2018 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.68%
|
634,812
|
$8,380,000 | — | 30 Sep 2018 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.64%
|
592,802
|
$7,825,000 | — | 30 Sep 2018 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.61%
|
562,413
|
$7,424,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.57%
|
527,337
|
$6,961,000 | — | 30 Sep 2018 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.52%
|
482,500
|
$6,369,000 | — | 30 Sep 2018 | |
| Opaleye Management Inc. |
13F
|
Company |
0.5%
|
465,200
|
$7,014,000 | — | 30 Sep 2018 | |
| Granite Point Capital Management, L.P. |
13F
|
Company |
0.5%
|
464,300
|
$6,129,000 | — | 30 Sep 2018 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.43%
|
400,000
|
$5,280,000 | — | 30 Sep 2018 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
0.42%
|
385,714
|
$5,091,000 | — | 30 Sep 2018 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.41%
|
379,484
|
$5,009,000 | — | 30 Sep 2018 | |
| Jefferies Group LLC |
13F
|
Company |
0.35%
|
325,630
|
$4,298,000 | — | 30 Sep 2018 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
315,000
|
$4,158,000 | — | 30 Sep 2018 | |
| Boxer Capital, LLC |
13F
|
Company |
0.32%
|
300,000
|
$3,960,000 | — | 30 Sep 2018 | |
| Artal Group S.A. |
13F
|
Company |
0.27%
|
250,000
|
$3,300,000 | — | 30 Sep 2018 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
237,683
|
$3,137,000 | — | 30 Sep 2018 | |
| Eversept Partners, LP |
13F
|
Company |
0.23%
|
209,739
|
$2,768,555 | — | 30 Sep 2018 | |
| David M. Knott |
13F
|
Individual |
0.19%
|
173,390
|
$2,289,000 | — | 30 Sep 2018 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.17%
|
155,100
|
$2,047,000 | — | 30 Sep 2018 | |
| Invesco Private Capital, Inc. |
13F
|
Company |
0.14%
|
129,539
|
$1,710,000 | — | 30 Sep 2018 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.13%
|
120,000
|
$1,584,000 | — | 30 Sep 2018 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.11%
|
100,000
|
$1,320,000 | — | 30 Sep 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.1%
|
88,692
|
$1,171,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
82,873
|
$1,094,000 | — | 30 Sep 2018 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
76,585
|
$1,011,000 | — | 30 Sep 2018 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.06%
|
57,086
|
$754,000 | — | 30 Sep 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
55,000
|
$726,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
52,413
|
$692,000 | — | 30 Sep 2018 | |
| JBF Capital, Inc. |
13F
|
Company |
0.04%
|
40,000
|
$528,000 | — | 30 Sep 2018 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.03%
|
28,767
|
$380,000 | — | 30 Sep 2018 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.03%
|
25,000
|
$330,000 | — | 30 Sep 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
19,500
|
$257,000 | — | 30 Sep 2018 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
19,275
|
$254,000 | — | 30 Sep 2018 | |
| Elmwood Wealth Management, Inc. |
13F
|
Company |
0.02%
|
18,729
|
$247,223 | — | 30 Sep 2018 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
16,074
|
$212,000 | — | 30 Sep 2018 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.02%
|
15,000
|
$198,000 | — | 30 Sep 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
11,721
|
$155,000 | — | 30 Sep 2018 | |
| Walleye Trading LLC |
13F
|
Company |
0.01%
|
11,470
|
$151,000 | — | 30 Sep 2018 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.01%
|
11,200
|
$148,000 | — | 30 Sep 2018 | |
| Trexquant Investment LP |
13F
|
Company |
0.01%
|
11,198
|
$148,000 | — | 30 Sep 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.01%
|
11,120
|
$147,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
10,298
|
$136,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
8,723
|
$115,000 | — | 30 Sep 2018 |
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Shares (XENE) as of Q4 2018
As of 31 Dec 2018,
Xenon Pharmaceuticals Inc. - Common Shares (XENE) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,450,658 shares.
The largest 10 holders included
venBio Select Advisor LLC, BVF INC/IL, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital World Investors, Aquilo Capital Management, LLC, Capital International Investors, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., and ORBIMED ADVISORS LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
59
Q4 2018 holders
56
Holder diff
-3
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.